![Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response | Communications Biology Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response | Communications Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs42003-022-03215-0/MediaObjects/42003_2022_3215_Fig1_HTML.png)
Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response | Communications Biology
![Antimalarial and anticancer properties of artesunate and other artemisinins: current development | SpringerLink Antimalarial and anticancer properties of artesunate and other artemisinins: current development | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00706-021-02759-x/MediaObjects/706_2021_2759_Sch8_HTML.png)
Antimalarial and anticancer properties of artesunate and other artemisinins: current development | SpringerLink
![Antimalarial and anticancer properties of artesunate and other artemisinins: current development | SpringerLink Antimalarial and anticancer properties of artesunate and other artemisinins: current development | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00706-021-02759-x/MediaObjects/706_2021_2759_Fig1_HTML.png)
Antimalarial and anticancer properties of artesunate and other artemisinins: current development | SpringerLink
![Antimalarial and anticancer properties of artesunate and other artemisinins: current development | SpringerLink Antimalarial and anticancer properties of artesunate and other artemisinins: current development | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00706-021-02759-x/MediaObjects/706_2021_2759_Fig11_HTML.png)
Antimalarial and anticancer properties of artesunate and other artemisinins: current development | SpringerLink
![Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study - The Lancet Infectious Diseases Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3ee0b991-be54-4340-9b2e-e1b5e9c7f18c/gr1_lrg.jpg)
Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study - The Lancet Infectious Diseases
![Full article: Isolation and structure elucidation of a steroidal moiety from Withania somnifera and in silico evaluation of antimalarial efficacy against artemisinin resistance Plasmodium falciparum kelch 13 protein Full article: Isolation and structure elucidation of a steroidal moiety from Withania somnifera and in silico evaluation of antimalarial efficacy against artemisinin resistance Plasmodium falciparum kelch 13 protein](https://www.tandfonline.com/action/showGraphicalAbstractImage?doi=10.1080%2F07391102.2022.2077448&type=img_lg&id=tbsd_a_2077448_uf0001_c.jpeg)
Full article: Isolation and structure elucidation of a steroidal moiety from Withania somnifera and in silico evaluation of antimalarial efficacy against artemisinin resistance Plasmodium falciparum kelch 13 protein
![Medicines | Free Full-Text | In Vitro and In Silico Antimalarial Evaluation of FM-AZ, a New Artemisinin Derivative | HTML Medicines | Free Full-Text | In Vitro and In Silico Antimalarial Evaluation of FM-AZ, a New Artemisinin Derivative | HTML](https://www.mdpi.com/medicines/medicines-09-00008/article_deploy/html/images/medicines-09-00008-g003.png)
Medicines | Free Full-Text | In Vitro and In Silico Antimalarial Evaluation of FM-AZ, a New Artemisinin Derivative | HTML
![Scoping Review of Antimalarial Drug Candidates in Phase I and II Drug Development | Antimicrobial Agents and Chemotherapy Scoping Review of Antimalarial Drug Candidates in Phase I and II Drug Development | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.01659-21/asset/c2c9568b-cfa6-40fb-9682-4e9ff32cb475/assets/images/large/aac.01659-21-f001.jpg)
Scoping Review of Antimalarial Drug Candidates in Phase I and II Drug Development | Antimicrobial Agents and Chemotherapy
![Dimeric Artesunate Glycerophosphocholine Conjugate Nano-Assemblies as Slow-Release Antimalarials to Overcome Kelch 13 Mutant Artemisinin Resistance | Antimicrobial Agents and Chemotherapy Dimeric Artesunate Glycerophosphocholine Conjugate Nano-Assemblies as Slow-Release Antimalarials to Overcome Kelch 13 Mutant Artemisinin Resistance | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.02065-21/asset/8d0300f2-ec88-4a5b-8f01-e82219dd20a8/assets/images/large/aac.02065-21-f001.jpg)
Dimeric Artesunate Glycerophosphocholine Conjugate Nano-Assemblies as Slow-Release Antimalarials to Overcome Kelch 13 Mutant Artemisinin Resistance | Antimicrobial Agents and Chemotherapy
![Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research - ScienceDirect Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523421000428-fx1.jpg)
Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research - ScienceDirect
![Some Swedish Hospitals Have Stopped Using Chloroquine to Treat COVID-19 After Reports of Severe Side Effects Some Swedish Hospitals Have Stopped Using Chloroquine to Treat COVID-19 After Reports of Severe Side Effects](https://d.newsweek.com/en/full/1579465/tablets-containing-chloroquine-plaqueril.jpg)
Some Swedish Hospitals Have Stopped Using Chloroquine to Treat COVID-19 After Reports of Severe Side Effects
![Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research - ScienceDirect Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523421000428-gr14.jpg)
Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research - ScienceDirect
![Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial - The Lancet Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a03d98eb-774e-4241-9059-a4f8e267ebf0/gr2_lrg.jpg)
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial - The Lancet
![Antimalarial and anticancer properties of artesunate and other artemisinins: current development | SpringerLink Antimalarial and anticancer properties of artesunate and other artemisinins: current development | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00706-021-02759-x/MediaObjects/706_2021_2759_Sch7_HTML.png)
Antimalarial and anticancer properties of artesunate and other artemisinins: current development | SpringerLink
![Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response | Communications Biology Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response | Communications Biology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs42003-022-03215-0/MediaObjects/42003_2022_3215_Fig4_HTML.png)
Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response | Communications Biology
![Pharmaceuticals | Free Full-Text | Studies of Potency and Efficacy of an Optimized Artemisinin-Quinoline Hybrid against Multiple Stages of the Plasmodium Life Cycle | HTML Pharmaceuticals | Free Full-Text | Studies of Potency and Efficacy of an Optimized Artemisinin-Quinoline Hybrid against Multiple Stages of the Plasmodium Life Cycle | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-01129/article_deploy/html/images/pharmaceuticals-14-01129-g001.png)
Pharmaceuticals | Free Full-Text | Studies of Potency and Efficacy of an Optimized Artemisinin-Quinoline Hybrid against Multiple Stages of the Plasmodium Life Cycle | HTML
![Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether | Antimicrobial Agents and Chemotherapy Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.00990-21/asset/20fa3ffb-ea73-4ab7-9b4a-11cd4e9abc40/assets/images/large/aac.00990-21-f0002.jpg)
Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether | Antimicrobial Agents and Chemotherapy
![Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial - The Lancet Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/96e65711-e3eb-4415-86c3-59ec9cae0cd9/gr1_lrg.gif)